Edition:
United States

Abbott Laboratories (ABT)

ABT on New York Consolidated

87.49USD
19 Jul 2019
Change (% chg)

$-0.27 (-0.31%)
Prev Close
$87.76
Open
$88.29
Day's High
$88.32
Day's Low
$87.45
Volume
5,824,075
Avg. Vol
5,389,750
52-wk High
$88.32
52-wk Low
$62.87

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 18 8,106.95 8,163.00 8,063.00 8,142.36
Quarter Ending Dec-19 18 8,329.89 8,475.00 8,247.05 8,525.36
Year Ending Dec-19 20 31,940.80 32,107.00 31,763.00 32,590.80
Year Ending Dec-20 20 34,226.30 35,167.00 33,698.00 34,602.20
Earnings (per share)
Quarter Ending Sep-19 20 0.84 0.86 0.83 0.83
Quarter Ending Dec-19 20 0.95 0.96 0.91 0.92
Year Ending Dec-19 22 3.24 3.26 3.22 3.23
Year Ending Dec-20 22 3.62 3.69 3.41 3.62
LT Growth Rate (%) 5 11.81 12.90 11.30 11.68
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 53.21 32.80 34.52
P/E High - Last 5 Yrs. 55.06 39.08 54.21
P/E Low - Last 5 Yrs. 25.95 24.36 28.29
Beta 1.11 0.78 0.99
Price to Sales (TTM) 4.99 6.48 7.97
Price to Book (MRQ) -- 5.76 4.45
Price to Tangible Book (MRQ) -- 7.96 5.18
Price to Cash Flow (TTM) 26.92 23.27 24.33
% Owned Institutions 76.01 4.99 1.75

Dividends

  Company industry sector
Dividend Yield 1.46 1.03 1.63
Dividend Yield - 5 Year Avg 1.97 1.12 1.37
Dividend 5 Year Growth Rate 14.87 12.10 6.83
Payout Ratio(TTM) 19.45 29.61 47.44

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 2.73 5.11 14.69
Sales (TTM) vs TTM 1 Yr. Ago 4.60 4.94 8.20
Sales - 5 Yr. Growth Rate 9.24 7.42 9.46
EPS (MRQ) vs Qtr. 1 Yr. Ago 38.97 45.16 18.14
EPS (TTM) vs TTM 1 Yr. Ago 25.77 -- --
EPS - 5 Yr. Growth Rate 1.97 16.11 7.10
Capital Spending - 5 Yr. Growth Rate 4.01 8.32 7.89

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.50 2.54
Current Ratio (MRQ) -- 3.24 3.54
LT Debt to Equity (MRQ) -- 18.77 12.58
Total Debt to Equity (MRQ) -- 22.99 17.60
Interest Coverage (TTM) 3.94 92.62 14.89

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 58.70 60.36 50.19
Gross Margin - 5 Yr. Avg. 56.39 60.56 51.31
EBITD Margin (TTM) 22.90 -- --
EBITD - 5 Yr. Avg 20.97 24.62 16.45
Operating Margin (TTM) 12.90 14.52 -6.60
Operating Margin - 5 Yr. Avg. 11.32 18.00 11.94
Pre-Tax Margin (TTM) 10.99 14.18 -6.95
Pre-Tax Margin - 5 Yr. Avg. 10.23 17.86 15.91
Net Profit Margin (TTM) 9.44 9.89 -10.73
Net Profit Margin - 5 Yr. Avg. 8.09 13.24 11.28
Effective Tax Rate (TTM) 14.06 22.36 20.55
Effective Tax Rate - 5 Yr. Avg. 20.88 25.17 24.50

Efficiency

  Company industry sector
Revenue/Employee (TTM) 300,340 26,913,777 879,617,670
Net Income/Employee (TTM) 28,359 3,160,937 102,957,990
Receivable Turnover (TTM) -- 4.78 5.90
Inventory Turnover (TTM) -- 3.07 3.64
Asset Turnover (TTM) -- 0.75 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.94 10.25
Return on Assets - 5 Yr. Avg. 3.63 10.20 11.20
Return on Investment (TTM) -- 14.10 12.69
Return on Investment - 5 Yr. Avg. 4.37 13.06 14.18
Return on Equity (TTM) -- 65.83 17.17
Return on Equity - 5 Yr. Avg. 7.92 16.79 15.55
  1 Year 3 Year 5 Year
Sales % 11.64 14.43 9.24
EPS (TTM) % 34.30 -7.00 1.97
Dividend % 5.66 5.27 14.87
Note: Units in Millions of US Dollars

Performance for Abbott Laboratories

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.93 2.03 99 58
13 Week 18.36 15.51 99 90
26 Week 22.50 9.91 99 91
52 Week 37.17 29.24 99 63
YTD 20.96 1.87 99 84
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 76.02%
# of Holders: 2,469
Total Shares Held: 1,341,164,045
3 Mo. Net Change: 1,826,291
# New Positions: 30
# Closed Positions: 11
# Increased Positions: 190
# Reduced Positions: 227
# Net Buyers: -37
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.